Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer

Cancer Research

Volumn 60, Issue 13, 2000, Pages 3550-3558

  Kawano, Kouichiro ^a   Gomi, Shinya ^a   Tanaka, Koji ^a   Tsuda, Naotake ^a   Kamura, Toshiharu ^a   Itoh, Kyogo ^a   Yamada, Akira ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; MEMBRANE PROTEIN;

AMINO ACID COMPOSITION; ANTIGEN RECOGNITION; ARTICLE; HLA SYSTEM; HUMAN; HUMAN CELL; LUNG CANCER; LYMPHOCYTIC INFILTRATION; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; AMINO ACID SEQUENCE; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 4; FEMALE; HLA-A ANTIGENS; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NEOPLASM PROTEINS; ORGAN SPECIFICITY; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0034234953     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
2. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., and Rosenberg, S. A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes. J. Exp. Med., 180: 347-352, 1994.
3. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA, 91: 6458-6462, 1994.
4. Brichard, V., Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178: 489-495, 1993.
5. Robbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., and Rosenberg, S. A. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med., 183: 1185-1192, 1996.
6. Guilloux, Y., Lucas, S., Brichard, V. G., Van Pel, A., Viret, C., De Plaen, E., Brasseur, F., Lethé, B., Jotereau, F., and Boon, T. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanoma is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. J. Exp. Med., 183: 1173-1183, 1996.
7. Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., and Boon, T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med., 182: 689-698, 1995.
8. Lupetti, R., Pisarra, P., Verrecchia, A., Farina, C., Nicolini, G., Anichini, A., Bordignon, C., Sensi, M., Parmiani, G., and Traversari, C. Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage. J. Exp. Med., 188: 1005-1016, 1998.
9. Peoples, G. E., Goedegebuure, P. S., Smith, R., Linehan, D. C., Yoshino, I., and Eberlein, T. J. Breast and ovarian cancer-specific cytotoxic T lymphocytes recognized the same HER2/neu-derived peptide. Proc. Natl. Acad. Sci. USA, 92: 432-436, 1995.
10. Fisk, B., Blevins, T. L., Wharton, J., and Ioannides, C. Identification of an immunodominant peptide of HER2/neu proto-oncogene recognized by ovarian tumor-specific cytotoxic T lymphocytes lines. J. Exp. Med., 181: 2109-2117, 1995.
11. Correale, P., Walmsley, K., Nieroda, C., Zaremba, S., Zhu, M., Schlom, J., and Tsang, K. Y. In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen. J. Natl. Cancer Inst., 89: 293-300, 1997.
12. Correale, P., Walmsley, K., Zaremba, S., Zhu, M., Schlom, J., and Tsang, K. Y. Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide. J. Immunol., 161: 3186-3194, 1998.
13. Shichijo, S., Nakao, M., Imai, Y., Takasu, H., Kawamoto, M., Niiya, F., Yang, D., Toh, Y., Yamana, H., and Itoh, K. A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes. J. Exp. Med., 187: 277-288, 1998.
14. Yang, D., Nakao, M., Shichijo, S., Sasatomi, S., Takasu, H., Matsumoto, H., Mori, K., Hayashi, A., Yamana, H., Shirouzu, K., and Itoh, K. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients. Cancer Res., 59: 4056-4063, 1999.
15. Gomi, S., Nakao, M., Niiya, F., Imamura, Y., Kawano, K., Nishizaka, S., Hayashi, A., Sobao, Y., Oizumi, K., and Itoh, K. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs. J. Immunol., 163: 4994-5004, 1999.
16. Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L. Spiess, P. J., Wunderlich, J. R., Parkhurst, M. A., Kawakami, Y., Seipp, C. A., Einhorn, J. H., and White, D. E. Immunologic and therapeutic evaluation of synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med., 4: 321-327, 1998.
17. Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., and Schadendorf, D. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat. Med., 4: 328-332, 1998.
18. Imanishi, T., Akaza, T., Kimura, A., Tokunaga, K., and Gojobori, T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: K. Tsuji, M. Aizawa, and T. Sasazuki (eds.), HLA 1991, Vol. 1, pp. 1065-1220. Oxford: Oxford Scientific Publications, 1992.
19. Seki, N., Hoshino, T., Kikuchi, M., Hayashi, A., and Itoh, K. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancel. Cell. Immunol., 175: 101-110, 1997.
20. Kikuchi, M., Nakao, M., Inoue, Y., Matsunaga, K., Shichijo, S., Yamana, H., and Itoh, K. Identification of a SART1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes. Int. J. Cancer, 81: 459-466, 1999.
21. Walter, M. A., Spillett, D. J., Thomas, P., Weissenbach, J., and Goodfellow, P. N. A method for constructing radiation hybrid maps of whole genomes. Nat. Genet., 7: 22-28, 1994.
22. Yamada, A., Kubo, K., Takeshita, T., Harashima, N., Kawano, K., Mine, T., Sagawa, K., and Itoh, K. Molecular cloning of a glycosylphosphophatidylinositol-anchored molecule CDw108. J. Immunol., 162: 4094-4100, 1999.
23. Shichijo, S., Hayashi, A., Takamori, S., Tsunosue, R., Hoshino, T., Sakata, M., Kuramoto, T., Oizumi, K., and Itoh, K. Detection of MAGE-4 protein in lung cancer. Int. J. Cancer, 54: 158-165, 1995.
24. Balch, W. E., Durphy, W. G., Braell, W. A., and Rothman, J. Reconstitution of the transport of protein between successive compartments of the Golgi measured by the coupled incorporation of N-acetylglucosamine. Cell, 39: 405-416, 1984.
25. Murakami, K., Mihara, K., and Omura, T. The transmembrane region of mucosal cytochrome P450 identified as the endoplasmic reticulum retention signal. J. Biochem., 116: 164-175, 1994.
26. Strobel, H. W., and Dignam, J. D. Purification and properties of NADPH cytochrome P-450 reductase. Methods Enzymol., 52: 89-96, 1978.
27. Prestle, J., Pfizenmaier, K., Brenner, J., and Johannes, F-J. Protein kinase Cμ is located at the Golgi compartment. J. Cell Biol., 134: 1401-1410, 1996.
28. Ibe, M., Moore, Y. I., Kaneko, Y., Yokota, S., and Takiguchi, M. Role of strong anchor residues in the effective binding of 10-mer and 11-mer peptides to HLA-A2402 molecules. Immunogenetics., 44: 233-241, 1996.
29. Rammensee, H-G., Friede, T., and Stevanovic, S. MHC ligands and peptide motifs: first listing. Immunogenetics, 41: 178-228, 1995.
30. Daniele, A., Altruda, F., Ferrone, M., Silengo, L., Chiarantini, L., Bianchi, M., Stocchi, V., and Magnani, M. Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli. Mol. Cell. Biochem., 107: 87-94, 1991.
31. Teasdale, R. D., and Jackson, M. R. Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the Golgi apparatus. Annu. Rev. Cell Dev. Biol., 12: 27-54, 1996.
32. Bram, R. J., and Crabtree, G. R. Calcium signaling in T cells stimulated by a cyclophilin B-binding protein. Nature (Lond.), 371: 355-358, 1994.
33. Arber, S., Krause, K-H., and Caroli, P. S-cyclophilin is retained intracellularly via a unique COOH-terminal sequence and colocalizes with the calcium storage protein calreticulin. J. Cell Biol., 116: 113-125, 1992.
34. Stryer, L. Protein targeting. In: L. Stryer (ed.), Biochemistry, Ed. 3, pp. 767-798. New York: W. H. Freeman and Company, 1988.
35. Worfel, T., Hauer, M., Schneider, J., Serrano, M., Worfel, C., Klehmann-Hieb, E., De Plan, E., Haukeln, T., Meyer zum Buschefede, K. H., and Beach, D. A. p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Washington DC), 269: 1281-1284, 1995.
36. Mandrazzato, S., Brasseur, F., Andry, G., Boon, T., and van der Bruggen, P. A CASP-8 mutation recognized by cytotoxic T lymphocytes on a human head and neck carcinoma. J. Exp. Med., 186: 785-793, 1997.